AI & Enterprise
Google, Meta to invest $300 million in \'virtual cells\' for AI disease research
Google DeepMind, Meta and AI drug discovery company Isomorphic Labs will invest a combined $300 million in a large AI biology project to study disease. The funding will support Biohub’s Virtual Biology initiative, which aims to build large biological datasets and develop virtual cell models to predict how cells respond to disease, drugs and other interventions. The effort will also draw on funding, data and computing and measurement technologies totalling $1.8 billion.